Non-Hematologic Malignancy
Information
- Disease name
- Non-Hematologic Malignancy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05077384 | Active, not recruiting | Phase 1/Phase 2 | Open-label Study of Surufatinib in Japanese Patients | September 2, 2021 | December 2024 |
NCT02412722 | Completed | Phase 1 | A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies | March 26, 2015 | May 31, 2018 |
NCT03625557 | Completed | Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records | April 30, 2019 | April 16, 2020 | |
NCT05968170 | Not yet recruiting | N/A | TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant | December 1, 2023 | July 1, 2035 |
NCT04285242 | Recruiting | Metabolic and Immunological Phenotyping in Patients With Cancer | December 7, 2021 | June 1, 2024 |